#Japan #Osaka #Health Safety #Kobayashi Pharmaceutical #Blue Mold

Controversy Surrounds Inspection Procedures at Kobayashi Pharmaceutical

The recent health hazards related to red yeast products have brought attention to the practices of Kobayashi Pharmaceutical, particularly regarding inspections by the Osaka health department. Investigations reveal that key samples, specifically those related to blue mold contamination, were obtained exclusively through voluntary submissions from the company. This has raised questions about the objectivity and integrity of the investigation process.

The Legal Framework

According to Article 28 of the Food Sanitation Law, it is stipulated that authorities have the right to collect samples (referred to as 'seizure') to ascertain the causes of foodborne illnesses. This legal framework emphasizes that investigations should rely on independently collected samples, ensuring objectivity and third-party verification. However, if the providing company is also under scrutiny, relying solely on voluntarily provided samples creates a significant conflict, undermining the integrity of the investigation.

Key Findings

Recent inquiries have revealed several critical points:

• - Osaka City has confirmed there is no documentation supporting that they conducted a seizure as mandated by the Food Sanitation Law.
• - It was disclosed that only samples provided by Kobayashi Pharmaceutical were utilized in the investigation.
• - A preliminary investigation document from July 17, 2024, indicates that samples labeled